Combining anti-IL-7Ra antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Combining anti-IL-7Ra antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.

Vazquez-Mateo C, Collins J, Goldberg SJ, Lawson M, Hernandez-Escalante J, Dooms H. Combining anti-IL-7Ra antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes. PLoS One. 2019; 14(3):e0214379.

View in: PubMed

subject areas

Animals
Antibodies, Monoclonal
Autoantigens
Cell Proliferation
Cytokines
Diabetes Mellitus, Type 1
Disease Models, Animal
Female
Immunization
Immunotherapy
Interleukin-7 Receptor alpha Subunit
Mice
Mice, Inbred NOD
T-Lymphocytes, Regulatory
Vaccination

authors with profiles

Hans Dooms

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium